Squarepoint’s Galena Biopharma RXII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
– Sell
-11,000
Closed -$16K – 1684
2015
Q4
$16K Buy
+11,000
New +$16K ﹤0.01% 1210

Other funds holding RXII

Squarepoint's RXII Position: Q1 2016 in Review

Squarepoint sold out of Galena Biopharma (RXII) in Q1 2016, closing a stake of 11,000 shares — an estimated $16K sold.

Squarepoint first reported a position in RXII in Q4 2015 and held it in 1 quarter. The position peaked at $16K in Q4 2015. 71 funds tracked by Wall St. Rank hold RXII as of Q1 2016.

  • Squarepoint reported no remaining Galena Biopharma position as of Q1 2016 after selling out during the quarter.
  • Squarepoint sold 11,000 Galena Biopharma shares in Q1 2016, an estimated $16K.
  • Squarepoint first reported a position in Galena Biopharma in Q4 2015 and held it in 1 quarter.
  • Squarepoint's Galena Biopharma position peaked at $16K in Q4 2015.
  • 71 funds tracked by Wall St. Rank held Galena Biopharma as of Q1 2016.

Based on Squarepoint's 13F filing for Q1 2016, filed 16 May 2016.